Dublin, Feb. 07, 2025 (GLOBE NEWSWIRE) — The “Biopharmaceutical Bioseparation Systems – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.
The global market for Biopharmaceutical Bioseparation Systems was valued at US$17.5 Billion in 2024 and is projected to reach US$32.6 Billion by 2030, growing at a CAGR of 10.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers and forecasts.
Biopharmaceutical bioseparation systems are critical components in the production and purification of biopharmaceuticals, which include therapeutic proteins, monoclonal antibodies, and vaccines. These systems employ various techniques such as chromatography, filtration, and centrifugation to separate and purify biological molecules from complex mixtures. The demand for biopharmaceuticals is increasing due to their effectiveness in treating chronic and rare diseases, driving the need for efficient and reliable bioseparation systems. These systems are essential for ensuring the purity, potency, and safety of biopharmaceutical products, which are subject to stringent regulatory requirements. Advances in bioseparation technologies are enhancing the efficiency and scalability of biopharmaceutical manufacturing processes.
The biopharmaceutical bioseparation market is experiencing significant growth due to the expanding biopharmaceutical industry and the increasing adoption of advanced bioseparation techniques. The rise in the prevalence of chronic diseases, the aging population, and the growing demand for personalized medicine are fueling the production of biopharmaceuticals. Additionally, the development of novel therapies such as gene and cell therapies is creating new challenges and opportunities for bioseparation technologies. Innovations in materials and methods, such as the use of single-use systems and continuous processing, are improving the efficiency and cost-effectiveness of bioseparation processes. These advancements are enabling the production of high-quality biopharmaceuticals at larger scales.
The growth in the biopharmaceutical bioseparation systems market is driven by several factors. Firstly, the increasing demand for biopharmaceuticals, driven by the prevalence of chronic diseases and the aging population, is boosting the need for efficient bioseparation systems. Secondly, advancements in bioseparation technologies, including single-use systems and continuous processing, are enhancing the scalability and cost-effectiveness of biopharmaceutical manufacturing. Thirdly, the development of novel therapies such as gene and cell therapies is creating new challenges and opportunities for bioseparation, driving innovation in this field. Lastly, stringent regulatory requirements for biopharmaceutical products are necessitating the use of advanced bioseparation systems to ensure product quality and safety. These factors collectively contribute to the robust growth of the biopharmaceutical bioseparation systems market.
Scope of the Study
The report analyzes the Biopharmaceutical Bioseparation Systems market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.
Segments:
- Technology (Chromatography, Other Technologies)
Geographic Regions/Countries:
- World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Chromatography Technology segment, which is expected to reach US$15.8 Billion by 2030 with a CAGR of a 10.2%. The Other Technologies segment is also set to grow at 11.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $7.3 Billion in 2024, and China, forecasted to grow at an impressive 13.3% CAGR to reach $3.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as 3M Company, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Alfa Laval AB, GEA Group AG and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Questions Answered:
- How is the Global Biopharmaceutical Bioseparation Systems Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 61 major companies featured in this Biopharmaceutical Bioseparation Systems market report include:
- 3M Company
- Agilent Technologies
- Bio-Rad Laboratories
- Alfa Laval AB
- GEA Group AG
- AMS Biotechnology (Europe) Ltd. (amsbio)
- Biotage AB
- AnteoTech
- BIA Separations d.o.o.
- Heinkel Drying and Separation Group
- 3B Pharmaceuticals GmbH
- Critical Process Filtration, Inc.
- Flottweg SE
- Ellutia
- Global Life Sciences Solutions USA LLC (Cytiva)
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 360 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $17.5 Billion |
| Forecasted Market Value (USD) by 2030 | $32.6 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Impact of COVID-19 on Biopharmaceutical Bioseparation Market
- Scope of Affinity Chromatography in Aiding the Vaccine Purification methodology
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024
- Biopharmaceutical Bioseparation Systems – Global Key Competitors Percentage Market Share in 2024
- A Prelude to Biopharmaceutical Bioseparation Systems
- A Peek into Biopharmaceutical Manufacturing
- Downstream Processing of Biosynthetic Products – An Overview
- Bioseparation Systems – Invaluable Tools in Biopharmaceutical Manufacturing
- US Remains Market Leader; Developing Countries to Drive Market Growth
- Chromatography Leads the Pack
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024
MARKET TRENDS & DRIVERS
- Growing Biopharmaceutical Market Drives Demand for Bioseparation Systems
- Top 10 Biopharmaceutical Companies: 2023
- Biological License Application (BLA) Approvals – 2023
- Targeted Therapies Gain Momentum, Cancer Immunotherapies on the Rise
- Process Intensification Aids in Greater Productivity
- Evolution of Chromatography Applications for the Biopharmaceutical Sector
- Chromatography in Cell & Gene Therapies
- Chromatography Methods Fraught with Issues
- Growing Biosimilars Market – A Clear Advantage for Bioseparation Technologies
- Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
- Progressive Regulatory Framework Accelerates Product Approvals & Subsequently Market Revenues
- Specific Guidelines for Biosimilars in Various Countries with Year of Publication
- Biosimilars Regulatory Agencies in Select Regional Markets
- Biosimilar Approvals in the US (2023)
- Biosimilar Approvals in Europe (2023)
- High Demand for Monoclonal Antibodies Generates Significant Opportunities for Bioseparation Systems
- Downstream Processing – A Major Trend among Biopharmaceutical Manufacturers
- Chromatography – The Gold Standard Separation Technology
- Global Chromatography Market (2023): Percentage Share Breakdown of Value Sales by Chromatography Techniques for Gas Chromatography, Liquid Chromatography, Supercritical Fluid Chromatography, Thin Layer Chromatography, and Others
- Increasing Demand for Gas Chromatography in Biopharma Separation
- Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
- A Comparison of Protein and Synthetic Ligands
- Pre-packed Disposable Columns in Chromatography Gain Attention
- SMBC – An Old Approach Gaining Significant Attention
- Major Advantages and Disadvantages of SMBC
- Twin-Column SMB – An Emerging Alternative to Protein A Columns
- Growing Focus on Alternatives to Protein A Chromatography
- Chiral Chromatography Increases in Popularity
- Chromatography Efficiency and Selectivity
- Mixed-Mode Chromatography
- Multimode Chromatography
- Mixed-Mode and Multimode Media Offer Cost Savings
- Flexible and Selective Chromatography Improves Biopharmaceutical Efficiencies
- Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
- His-tagged purification of protein & Immobilized Metal Affinity Chromatography (IMAC)
- Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
- Downstream Production of Biopharmaceuticals: Filtration Challenges
- Evolving Membrane Functions in Filtration for the Production of mAbs
- Filtration Technology: The Future
- Membrane Adsorbers Gain Ground in Biopharmaceutical Downstream Purification
- Prospering Vaccine Market Drives Use of Ultrafiltration Techniques
- Membrane & Bioseparation
- Need for Highly Efficient Membranes Rises
- Downstream Response of Industry to Upstream Scale-Up
- Hand-powered Centrifuge setup can Diagnose COVID-19 for just a dollar a test
- Cell Disruption & Methods Gain Popularity
- Advent of Innovative Technologies Streamline and Enhance Production of Biopharmaceutical Systems
- Affinity Technologies Improve Productivity
- Nanofiber Chromatography Technology Advantageous
- Convective Media Set to Gain Growing Use
- Nanotechnology Set to Add Interesting Dimension to Biological Separation
- Rise of Magnetic Nanoparticles
- Magnetic Biological Separation: Key Steps
- Why Carbon Nanotubes are Gaining Attention
- Application of Nanoporous & Nanofiber Membranes
- Key Challenges & the Road Ahead
- Continuous Bioprocessing Holds Potential to Positively Impact Biomanufacturing
- Perfusion Gains Attention
- Use of Continuous Purification on the Rise in Viral Processes
- Introduction of Integrated Continuous Bioprocessing System Improves Productivity and Minimizes Raw Material Wastage
- Use of Continuous Processing Technique for Manufacturing Life-Saving Medicines Gains Momentum
- Demand for Sustainable Nanofiber Chromatography Mechanism Witnesses an Upward Momentum
- Use of Precipitation Technique for Purifying Therapeutic Proteins Exhibits a Surge
- Continuous Bioseparation Gains Momentum
- Single-Use Systems Play a Key Role
- Minimizing Centrifugation Steps
- Single-Use Disposable Technologies Gain Attention
- Innovative Approaches to Overcome Perennial & Existing Challenges with Process Chromatography
- Increase in Healthcare Spending Stirs Demand for Biopharmaceutical Bioseperation Systems
- Growing Preference for Personalized Medicine to Drive Market Growth
For more information about this report visit https://www.researchandmarkets.com/r/cvjo16
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Biopharmaceutical Bioseparation Systems Market
